Shenzhen Neptunus Bioengineering Hits Day Low Amid Price Pressure at CNY 2.86

Shenzhen Neptunus Bioengineering Co., Ltd. experienced a significant decline today, with its stock price dropping by 5.25% as it reached an intraday low of CNY 2.86. This performance stands in contrast to the broader market, as the China Shanghai Composite index fell by 3.63% during the same period. Over the past week, Shenzhen Neptunus has seen a more pronounced downturn, with a 12.16% decrease, and its monthly performance reflects a 16.23% drop. Year-to-date, the stock has declined by 16.47%, while its performance over the last three years shows a decrease of 14.24%. In stark contrast, the company has managed a 17.96% increase over the past year, outperforming the China Shanghai Composite's 13.33% gain. Financial metrics indicate challenges for Shenzhen Neptunus, including a high debt-to-equity ratio of 5.13 and a return on equity of -40.80%. The company's net profit for the first nine months has decreased by 41.86%, and net sales have also contracted by 14.13%. These figures highlight the ongoing difficulties faced by the company in the retailing sector.